Skip to main content
Erschienen in: International Journal of Legal Medicine 2/2018

01.12.2017 | Case Report

The feasibility of physiologically based pharmacokinetic modeling in forensic medicine illustrated by the example of morphine

verfasst von: Nadine Schaefer, Daniel Moj, Thorsten Lehr, Peter H. Schmidt, Frank Ramsthaler

Erschienen in: International Journal of Legal Medicine | Ausgabe 2/2018

Einloggen, um Zugang zu erhalten

Abstract

In forensic medicine, expert opinion is often required concerning dose and time of intake of a substance, especially in the context of fatal intoxications. In the present case, a 98-year-old man died 4 days after admission to a hospital due to a femur neck fracture following a domestic fall in his retirement home. As he had obtained high morphine doses in the context of palliative therapy and a confusion of his supplemental magnesium tablets with a diuretic by the care retirement home was suspected by the relatives, a comprehensive postmortem examination was performed. Forensic toxicological GC- and LC-MS analyses revealed, besides propofol, ketamine, and a metamizole metabolite in blood and urine, toxic blood morphine concentrations of approximately 3 mg/l in femoral and 5 mg/l in heart blood as well as 2, 7, and 10 mg/kg morphine in brain, liver, and lung, respectively. A physiologically based pharmacokinetic (PBPK) model was developed and applied to examine whether the morphine concentrations were (i) in agreement with the morphine doses documented in the clinical records or (ii) due to an excessive morphine administration. PBPK model simulations argue against an overdosing of morphine. The immediate cause of death was respiratory and cardiovascular failure due to pneumonia following a fall, femur neck fracture, and immobilization accompanied by a high and probably toxic concentration of morphine, attributable to the administration under palliative care conditions. The presented case indicates that PBPK modeling can be a useful tool in forensic medicine, especially in question of a possible drug overdosing.
Literatur
5.
9.
Zurück zum Zitat Mahmood I, Ahmad T, Mansoor N, Sharib SM (2017) Prediction of clearance in neonates and infants (≤ 3 months of age) for drugs that are glucuronidated: a comparative study between allometric scaling and physiologically based pharmacokinetic modeling. J Clin Pharmacol 57(4):476–483. https://doi.org/10.1002/jcph.837 CrossRefPubMed Mahmood I, Ahmad T, Mansoor N, Sharib SM (2017) Prediction of clearance in neonates and infants (≤ 3 months of age) for drugs that are glucuronidated: a comparative study between allometric scaling and physiologically based pharmacokinetic modeling. J Clin Pharmacol 57(4):476–483. https://​doi.​org/​10.​1002/​jcph.​837 CrossRefPubMed
11.
Zurück zum Zitat Workgroup EM, Marshall SF, Burghaus R, Cosson V, Cheung SYA, Chenel M, DellaPasqua O, Frey N, Hamrén B, Harnisch L, Ivanow F, Kerbusch T, Lippert J, Milligan PA, Rohou S, Staab A, Steimer JL, Tornøe C, Visser SAG (2016) Good practices in model-informed drug discovery and development: practice, application, and documentation. CPT: Pharmacometrics Syst Pharmacol 5(3):93–122. https://doi.org/10.1002/psp4.12049 Workgroup EM, Marshall SF, Burghaus R, Cosson V, Cheung SYA, Chenel M, DellaPasqua O, Frey N, Hamrén B, Harnisch L, Ivanow F, Kerbusch T, Lippert J, Milligan PA, Rohou S, Staab A, Steimer JL, Tornøe C, Visser SAG (2016) Good practices in model-informed drug discovery and development: practice, application, and documentation. CPT: Pharmacometrics Syst Pharmacol 5(3):93–122. https://​doi.​org/​10.​1002/​psp4.​12049
15.
Zurück zum Zitat National Guideline C (2012) Opioids in palliative care: safe and effective prescribing of strong opioids for pain in palliative care of adults National Guideline C (2012) Opioids in palliative care: safe and effective prescribing of strong opioids for pain in palliative care of adults
21.
Zurück zum Zitat Oosten AW, Abrantes JA, Jönsson S, Matic M, van Schaik RHN, de Bruijn P, van der Rijt CCD, Mathijssen RHJ (2016) A prospective population pharmacokinetic study on morphine metabolism in cancer patients. Clin Pharmacokinet :1–14. doi:https://doi.org/10.1007/s40262-016-0471-7 Oosten AW, Abrantes JA, Jönsson S, Matic M, van Schaik RHN, de Bruijn P, van der Rijt CCD, Mathijssen RHJ (2016) A prospective population pharmacokinetic study on morphine metabolism in cancer patients. Clin Pharmacokinet :1–14. doi:https://​doi.​org/​10.​1007/​s40262-016-0471-7
25.
Zurück zum Zitat Achour B, Russell MR, Barber J, Rostami-Hodjegan A (2014) Simultaneous quantification of the abundance of several cytochrome P450 and uridine 5′-diphospho-glucuronosyltransferase enzymes in human liver microsomes using multiplexed targeted proteomics. Drug Metab Dispos 42(4):500–510. https://doi.org/10.1124/dmd.113.055632 CrossRefPubMed Achour B, Russell MR, Barber J, Rostami-Hodjegan A (2014) Simultaneous quantification of the abundance of several cytochrome P450 and uridine 5′-diphospho-glucuronosyltransferase enzymes in human liver microsomes using multiplexed targeted proteomics. Drug Metab Dispos 42(4):500–510. https://​doi.​org/​10.​1124/​dmd.​113.​055632 CrossRefPubMed
27.
Zurück zum Zitat Willmann S, Hohn K, Edginton A, Sevestre M, Solodenko J, Weiss W, Lippert J, Schmitt W (2007) Development of a physiology-based whole-body population model for assessing the influence of individual variability on the pharmacokinetics of drugs. J Pharmacokinet Pharmacodyn 34(3):401–431. https://doi.org/10.1007/s10928-007-9053-5 CrossRefPubMed Willmann S, Hohn K, Edginton A, Sevestre M, Solodenko J, Weiss W, Lippert J, Schmitt W (2007) Development of a physiology-based whole-body population model for assessing the influence of individual variability on the pharmacokinetics of drugs. J Pharmacokinet Pharmacodyn 34(3):401–431. https://​doi.​org/​10.​1007/​s10928-007-9053-5 CrossRefPubMed
30.
31.
Zurück zum Zitat Thelen K, Coboeken K, Willmann S, Dressman JB, Lippert J (2012) Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, part II: extension to describe performance of solid dosage forms. J Pharm Sci 101(3):1267–1280. https://doi.org/10.1002/jps.22825 CrossRefPubMed Thelen K, Coboeken K, Willmann S, Dressman JB, Lippert J (2012) Evolution of a detailed physiological model to simulate the gastrointestinal transit and absorption process in humans, part II: extension to describe performance of solid dosage forms. J Pharm Sci 101(3):1267–1280. https://​doi.​org/​10.​1002/​jps.​22825 CrossRefPubMed
39.
Zurück zum Zitat Chau N, Elliot DJ, Lewis BC, Burns K, Johnston MR, Mackenzie PI, Miners JO (2014) Morphine glucuronidation and glucosidation represent complementary metabolic pathways that are both catalyzed by UDP-glucuronosyltransferase 2B7: kinetic, inhibition, and molecular modeling studies. J Pharmacol Exp Ther 349(1):126–137. https://doi.org/10.1124/jpet.113.212258 CrossRefPubMed Chau N, Elliot DJ, Lewis BC, Burns K, Johnston MR, Mackenzie PI, Miners JO (2014) Morphine glucuronidation and glucosidation represent complementary metabolic pathways that are both catalyzed by UDP-glucuronosyltransferase 2B7: kinetic, inhibition, and molecular modeling studies. J Pharmacol Exp Ther 349(1):126–137. https://​doi.​org/​10.​1124/​jpet.​113.​212258 CrossRefPubMed
43.
Zurück zum Zitat Baselt, R.C, Cravey RH (2014). In: Disposition of toxic drugs and chemicals in man, 10th edition. Biomedical Publications, Seal Beach, California (USA), pp 1399–1403 Baselt, R.C, Cravey RH (2014). In: Disposition of toxic drugs and chemicals in man, 10th edition. Biomedical Publications, Seal Beach, California (USA), pp 1399–1403
54.
Zurück zum Zitat Villesen HH, Banning A-M, Petersen RH, Weinelt S, Poulsen JB, Hansen SH, Christrup LL (2007) Pharmacokinetics of morphine and oxycodone following intravenous administration in elderly patients. Ther Clin Risk Manag 3(5):961–967PubMedPubMedCentral Villesen HH, Banning A-M, Petersen RH, Weinelt S, Poulsen JB, Hansen SH, Christrup LL (2007) Pharmacokinetics of morphine and oxycodone following intravenous administration in elderly patients. Ther Clin Risk Manag 3(5):961–967PubMedPubMedCentral
Metadaten
Titel
The feasibility of physiologically based pharmacokinetic modeling in forensic medicine illustrated by the example of morphine
verfasst von
Nadine Schaefer
Daniel Moj
Thorsten Lehr
Peter H. Schmidt
Frank Ramsthaler
Publikationsdatum
01.12.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
International Journal of Legal Medicine / Ausgabe 2/2018
Print ISSN: 0937-9827
Elektronische ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-017-1754-8

Weitere Artikel der Ausgabe 2/2018

International Journal of Legal Medicine 2/2018 Zur Ausgabe

Neu im Fachgebiet Rechtsmedizin